CME Group Inc. (NASDAQ:CME) Insider Sells $1,304,836.50 in Stock

CME Group Inc. (NASDAQ:CME) insider Derek Sammann sold 4,650 shares of CME Group stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the completion of the transaction, the insider now owns 8,336 shares of the company’s stock, valued at approximately $2,339,164.96. The trade was a 35.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

CME Group Trading Up 0.8 %

Shares of CME Group stock opened at $284.35 on Friday. The business has a fifty day simple moving average of $264.47 and a 200-day simple moving average of $245.55. The firm has a market cap of $102.47 billion, a price-to-earnings ratio of 29.41, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $286.48. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the firm posted $2.50 EPS. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a $1.25 dividend. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.76%. CME Group’s dividend payout ratio is currently 50.30%.

Institutional Investors Weigh In On CME Group

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in CME Group by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider’s stock worth $9,190,661,000 after purchasing an additional 400,737 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of CME Group by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider’s stock worth $1,946,717,000 after buying an additional 104,697 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider’s stock worth $1,923,047,000 after acquiring an additional 3,921,278 shares in the last quarter. Norges Bank acquired a new stake in shares of CME Group during the fourth quarter valued at approximately $1,107,389,000. Finally, FIL Ltd lifted its position in shares of CME Group by 1.5% in the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider’s stock valued at $947,821,000 after acquiring an additional 61,908 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CME shares. UBS Group boosted their price objective on CME Group from $290.00 to $305.00 and gave the company a “buy” rating in a research report on Friday, April 25th. Piper Sandler boosted their price target on shares of CME Group from $275.00 to $283.00 and gave the company an “overweight” rating in a report on Tuesday, April 8th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. Oppenheimer upped their target price on shares of CME Group from $269.00 to $279.00 and gave the stock an “outperform” rating in a research report on Friday, April 11th. Finally, Bank of America raised their price target on shares of CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research note on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus target price of $256.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.